Investors were hoping for better initial data from an early-stage trial of its prostate cancer therapy.
Key Data Points
Primary metrics and data points about Arvinas Inc.
of CAPS members think ARVN will outperform the market
What Fools think
The single most important factor in a company's success is the team that's leading the company